Delivery Order SPE2DE24D0013-SPE2D626F26LV
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a $9,520 firm fixed-price delivery order to Cepheid Inc. on January 27, 2026, for diagnostic supplies and reagents. This delivery order, designated XPRS4PLEX-10, is scheduled for completion by February 3, 2026, and represents a child contract under Cepheid's larger indefinite delivery vehicle with the Department of Veterans Affairs. The contract involves no set-aside designation and will be performed at Cepheid's headquarters in...
- The Defense Logistics Agency Medical Supply Chain awarded a $2,040 firm fixed-price delivery order to Cepheid Inc. on January 20, 2026, with an ultimate completion date of January 27, 2026. This delivery order, designated XPRS4PLEX-10, represents a child contract under Cepheid's larger Indefinite Delivery Contract framework with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at $6.74 million through December 28, 2029. The delivery order procures...
- The Defense Logistics Agency Medical Supply Chain awarded Cepheid Inc. a firm fixed-price delivery order valued at $36,720 on January 23, 2026, with completion expected by January 30, 2026. This delivery order, designated XPRS4PLEX-10, represents a child contract under Cepheid's single-award Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at $6.7 million through December 28, 2029. The contract does not utilize a set-aside...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,310.00 under contract XPRS-COV2-10 by the Defense Logistics Agency Medical Supply Chain on January 26, 2026, with ultimate completion by February 2, 2026. This firm fixed-price delivery order, issued without set-aside designation, represents a child contract under Cepheid's larger Indefinite Delivery Vehicle with the Department of Veterans Affairs Veterans Integrated Service Network 17 (valued at $6.7...
- The Defense Logistics Agency Medical Supply Chain has awarded a delivery order valued at $8,976 to Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems and reagents. This firm fixed-price delivery order, issued on January 23, 2026, with an ultimate completion date of January 30, 2026, represents a child contract under a larger Indefinite Delivery Vehicle (IDV) with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 6, valued...
- The Defense Logistics Agency Medical Supply Chain awarded a $5,440 firm fixed-price delivery order to Cepheid Inc. on January 13, 2026, with an ultimate completion date of January 21, 2026. This delivery order, identified as XPRS4PLEX-10, is a child contract issued under Cepheid's existing Indefinite Delivery Contract with the Department of Veterans Affairs VISN 6, valued at $32.8 million and extending through September 30, 2030. The contract involves the supply of molecular diagnostic testing...
- The Defense Logistics Agency Medical Supply Chain awarded a $8,640 firm fixed-price delivery order to Cepheid Inc. on January 21, 2026, for diagnostic reagents and test kits. This delivery order, valued at the ceiling amount, represents a child contract under Cepheid's larger Indefinite Delivery Contract (IDC) vehicle with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, which is valued at $6.74 million through December 28, 2029. The delivery order is for...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, was awarded a $3,850 firm fixed-price delivery order (Contract No. XPRS-COV2-10) by the Defense Logistics Agency Medical Supply Chain on January 27, 2026, with completion scheduled for February 3, 2026. This delivery order falls under Cepheid's broader single-award Indefinite Delivery Contract with the Department of Veterans Affairs Veterans Integrated Service Network (VISN) 17, valued at $6.74 million through...
- The Defense Logistics Agency Medical Supply Chain has awarded a delivery order valued at $14,552 to Cepheid Inc. under an Indefinite Delivery Contract with the Department of Veterans Affairs VISN 17. This firm fixed-price delivery order, issued on January 21, 2026, with an ultimate completion date of January 28, 2026, pertains to XPRS4PLEX-10 cartridges—molecular diagnostic reagents designed for Cepheid's GeneXpert diagnostic platform. The order represents a child contract without set-aside...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a $8,160 delivery order (4570311575 | XPRS4PLEX-10) by the Defense Logistics Agency's Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 22, 2025. This firm fixed-price delivery order, which carries no set-aside designation, falls under a larger single-award Indefinite Delivery Contract valued at $6.7 million with the Department of Veterans...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F26LVDelivery Order
This delivery order, valued at $2,182.80, was awarded by the Defense Logistics Agency Medical Supply Chain to Cepheid Inc. on January 26, 2026, for the provision of XPRS4PLEX-10 diagnostic cartridges under a firm fixed-price contract structure with no set-aside designation. The order is a child contract under Cepheid's broader Indefinite Delivery Vehicle with the Department of Veterans Affairs Veterans Integrated Service Network 17, valued at $6.7 million through December 28, 2029, which establishes the framework for ongoing procurement of molecular diagnostic reagents and test kits for the GeneXpert diagnostic platform. Performance is scheduled to conclude by February 2, 2026, with work to be executed at Cepheid's headquarters in Sunnyvale, California. Cepheid is a specialized manufacturer of advanced molecular diagnostic systems and reagents headquartered in Sunnyvale, California, with established relationships across multiple federal healthcare agencies including the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and the U.S. Coast Guard. The company's core expertise in rapid molecular diagnostic testing for infectious diseases including COVID-19, influenza, respiratory syncytial virus, and other pathogens positions it as a primary federal supplier of diagnostic solutions. The modest value of this particular delivery order reflects routine replenishment procurement under the larger VA contracting vehicle that supports clinical laboratory operations and infectious disease testing requirements across the federal healthcare system's distributed network of medical centers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 1/25/26 |